Consensus Waters Corporation

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 01:00:02 14/01/2026 +04			5-day change	1st Jan Change
394.03 ^USD	+0.09%		-1.63%	+3.74%

01-13	Waters Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 02:15 PM
01-07	Leerink Partners Adjusts Price Target on Waters to $425 From $400, Maintains Outperform Rating	MT

Evolution of the Average Target: Waters Corporation

Evolution of the Target Price: Waters Corporation

Changes in Analyst Recommendations: Waters Corporation

b2f730e60249a0b4087.sgz90Nw4FFEAwziXrah1XeN4nBJpKw0mGhUjikBbuiQ.1jywj4VPJylZinzf2OkFF7c693gaHVpgTX1W8gUL5V3wbY-kvk8lFGSuDA~dcbac3970643c5b4471d4b6ce1f93b21

Analysts' recommendations: Waters Corporation

01-07	Leerink Partners Adjusts Price Target on Waters to $425 From $400, Maintains Outperform Rating	MT
01-06	Guggenheim Initiates Waters at Buy With $440 Price Target	MT
01-05	William Blair Initiates Waters at Outperform	MT
12-19	Deutsche Bank Adjusts Waters Price Target to $370 From $355, Maintains Hold Rating	MT
12-17	Jefferies Adjusts Price Target on Waters to $470 From $405, Maintains Buy Rating	MT
12-16	Rothschild & Co Redburn Adjusts Price Target on Waters to $460 From $430, Maintains Buy Rating	MT
12-15	Wells Fargo Adjusts PT on Waters to $415 From $385, Maintains Equalweight Rating	MT
12-10	Waters Shares Rise After Wolfe Research Upgrade	MT
12-10	Wolfe Research Upgrades Waters to Outperform From Peer Perform, Price Target is $480	MT
12-02	Agilent, Waters Face Diverging Outlooks on Growth and Integration Risks, Morgan Stanley Says	MT
12-02	Morgan Stanley Initiates Waters at Equalweight With $423 Price Target	MT
11-14	TD Cowen Adjusts Price Target on Waters to $400 From $390, Maintains Hold Rating	MT
11-05	Baird Adjusts Price Target on Waters to $398 From $386, Maintains Outperform Rating	MT
11-05	Wells Fargo Adjusts Price Target on Waters to $385 From $315, Maintains Equalweight Rating	MT
11-05	JPMorgan Adjusts Price Target on Waters to $360 From $325, Maintains Neutral Rating	MT
11-05	Stifel Adjusts Price Target on Waters to $380 From $360, Maintains Hold Rating	MT
11-05	TD Cowen Adjusts Price Target on Waters to $390 From $345, Maintains Hold Rating	MT
11-05	Deutsche Bank Adjusts Price Target on Waters to $355 From $335, Maintains Hold Rating	MT
11-05	Rothschild & Co Redburn Adjusts Price Target on Waters to $430 From $390, Maintains Buy Rating	MT
11-05	Analyst recommendations: Fiserv, Alphabet, AMD, Dupont De Nemours, Palantir…
11-04	Baird Adjusts Price Target on Waters to $386 From $344, Maintains Outperform Rating	MT
11-04	Deutsche Bank Adjusts Waters Price Target to $335 From $330, Maintains Hold Rating	MT
20/10/25	BofA Securities Adjusts Price Target on Waters to $350 From $330	MT
16/10/25	Deutsche Bank Adjusts Waters Price Target to $330 From $315, Maintains Hold Rating	MT
14/10/25	TD Cowen Adjusts Price Target on Waters to $345 From $322, Maintains Hold Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	WATERS CORPORATION					+4.06%
	THERMO FISHER SCIENTIFIC, INC.					+7.32%
	INTUITIVE SURGICAL, INC.					+8.27%
	DANAHER CORPORATION					+10.82%
	BOSTON SCIENTIFIC CORPORATION					+33.26%
	SIEMENS HEALTHINEERS AG					+19.72%
	EDWARDS LIFESCIENCES CORPORATION					+15.33%
	AGILENT TECHNOLOGIES, INC.					+15.54%
	GE HEALTHCARE TECHNOLOGIES INC.					+8.29%
	RESMED, INC.					+14.58%
	Average					+13.72%
	Weighted average by Cap.					+13.53%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

394.03USD

Average target price

410.01USD

Spread / Average Target

+4.06%

High Price Target

480.00USD

Spread / Highest target

+21.82%

Low Price Target

348.15USD

Spread / Lowest Target

-11.64%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Leerink Partners
Guggenheim
William Blair & Co.
Deutsche Bank Securities
Jefferies & Co.
Rothschild & Co Redburn
Wells Fargo Securities
Wolfe Research
Morgan Stanley
TD Cowen
Baird
JPMorgan Chase
Stifel Nicolaus
BofA Securities
UBS
Bernstein
Scotiabank
Barclays
Citigroup
Nephron Research
Evercore ISI
KeyBanc Capital Markets
Goldman Sachs
Morningstar
SVB Securities LLC
Credit Suisse
SVB Leerink